Aurora Cannabis to buy CanniMed Therapeutics for $1.1 billion

Aurora Cannabis Inc. has struck a friendly deal valued at $1.1 billion to buy rival licensed producer CanniMed Therapeutics Inc., bringing an end to a hostile takeover battle between the marijuana companies. Aurora has agreed to pay $43 per share in stock and cash for each CanniMed share. Read More

The post Aurora Cannabis to buy CanniMed Therapeutics for $1.1 billion appeared first on Dagga Magazine.

…read more

Leave a Reply

Your email address will not be published. Required fields are marked *